Total Neoadjuvant Therapy In Locally Advanced Rectal Cancer: A New Approach
Lusiadas Scientific Journal · 15.11.2023
DOI: 10.48687/lsj.186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lusiadas Scientific Journal, erschienen am 15.11.2023. Verfasst von Pissarra und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Locally advanced rectal cancer (LARC) is a relatively common disease, with a poor prognosis because of its high metastatic potential. Gold standard in the treatment for LARC includes concurrent chemoradiotherapy (CRT) followed by surgery and adjuvant chemotherapy. An alternative strategy known as total neoadjuvant therapy (TNT) involves administration of CRT plus neoadjuvant chemotherapy before surgery with the goal of delivering uninterrupted systemic therapy to eradicate micrometastasis. Recent data suggests that TNT delivers superior rates of pathologic complete responses with similar disease-free and overall survival, compared to standard approach. Additionally, it may allow an increased number of patients entering organ preservation programs. In light of a clinical case, the authors review this controversial but very contemporary issue.
Schlagwörter
Zitieren
APA
Pissarra, Ana, Luis, Joana, Macedo, Daniela, Chinita, P., & Figueiredo, N. (2023). Total Neoadjuvant Therapy In Locally Advanced Rectal Cancer: A New Approach. Lusiadas Scientific Journal. https://doi.org/10.48687/lsj.186
Vancouver
Pissarra, Ana, Luis, Joana, Macedo, Daniela, et al. Total Neoadjuvant Therapy In Locally Advanced Rectal Cancer: A New Approach. Lusiadas Scientific Journal. 2023. doi:10.48687/lsj.186
BibTeX
@article{Pissarra2023,
author = {Pissarra and Ana and Luis and Joana and Macedo and Daniela and Chinita, P. and Figueiredo, Nuno},
title = {Total Neoadjuvant Therapy In Locally Advanced Rectal Cancer: A New Approach},
journal = {Lusiadas Scientific Journal},
year = {2023},
doi = {10.48687/lsj.186}
}
EUVIMED